127 related articles for article (PubMed ID: 8988699)
1. A double-blind randomised controlled trial of the effects of medroxyprogesterone acetate on bone density of women taking oestrogen replacement therapy.
Adachi JD; Sargeant EJ; Sagle MA; Lamont D; Fawcett PD; Bensen WG; McQueen M; Nazir DJ; Goldsmith CH
Br J Obstet Gynaecol; 1997 Jan; 104(1):64-70. PubMed ID: 8988699
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
[TBL] [Abstract][Full Text] [Related]
3. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
[TBL] [Abstract][Full Text] [Related]
4. Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post-menopausal women.
Grey A; Cundy T; Evans M; Reid I
Clin Endocrinol (Oxf); 1996 Mar; 44(3):293-6. PubMed ID: 8729524
[TBL] [Abstract][Full Text] [Related]
5. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
Gallagher JC; Kable WT; Goldgar D
Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
[TBL] [Abstract][Full Text] [Related]
7. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
[TBL] [Abstract][Full Text] [Related]
8. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
[TBL] [Abstract][Full Text] [Related]
9. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
[TBL] [Abstract][Full Text] [Related]
11. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
Osteoporos Int; 2005 Apr; 16(4):372-9. PubMed ID: 15654581
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
13. Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.
Civitelli R; Pilgram TK; Dotson M; Muckerman J; Lewandowski N; Armamento-Villareal R; Yokoyama-Crothers N; Kardaris EE; Hauser J; Cohen S; Hildebolt CF
Arch Intern Med; 2002 Jun; 162(12):1409-15. PubMed ID: 12076241
[TBL] [Abstract][Full Text] [Related]
14. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D
N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759
[TBL] [Abstract][Full Text] [Related]
15. Effects of estrone sulfate alone or with medroxyprogesterone acetate on serum lipoprotein levels in postmenopausal women.
Luciano AA; Miller BE; Schoenenfeld MJ; Schaser RJ;
Obstet Gynecol; 2001 Jan; 97(1):101-8. PubMed ID: 11152917
[TBL] [Abstract][Full Text] [Related]
16. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.
Lobo RA; Bush T; Carr BR; Pickar JH
Fertil Steril; 2001 Jul; 76(1):13-24. PubMed ID: 11438314
[TBL] [Abstract][Full Text] [Related]
17. Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women.
Wolfe BM; Koval JJ; Nisker JA
Am J Obstet Gynecol; 1998 Apr; 178(4):787-92. PubMed ID: 9579445
[TBL] [Abstract][Full Text] [Related]
18. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
Walsh BW; Kuller LH; Wild RA; Paul S; Farmer M; Lawrence JB; Shah AS; Anderson PW
JAMA; 1998 May; 279(18):1445-51. PubMed ID: 9600478
[TBL] [Abstract][Full Text] [Related]
19. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
[TBL] [Abstract][Full Text] [Related]
20. Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and high-density lipoproteins.
Lamon-Fava S; Posfai B; Asztalos BF; Horvath KV; Dallal GE; Schaefer EJ
Metabolism; 2003 Oct; 52(10):1330-6. PubMed ID: 14564686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
